151 related articles for article (PubMed ID: 36609596)
1. Five-year survival of patients with late-stage prostate cancer: comparison of the Military Health System and the U.S. general population.
Lin J; Nousome D; Jiang J; Chesnut GT; Shriver CD; Zhu K
Br J Cancer; 2023 Apr; 128(6):1070-1076. PubMed ID: 36609596
[TBL] [Abstract][Full Text] [Related]
2. Survival among Breast Cancer Patients: Comparison of the U.S. Military Health System with the Surveillance, Epidemiology and End Results Program.
Lin J; Hu H; Shriver CD; Zhu K
Clin Breast Cancer; 2022 Jun; 22(4):e506-e516. PubMed ID: 34961733
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Survival among Colon Cancer Patients in the U.S. Military Health System and Patients in the Surveillance, Epidemiology, and End Results (SEER) Program.
Lin J; McGlynn KA; Shriver CD; Zhu K
Cancer Epidemiol Biomarkers Prev; 2021 Jul; 30(7):1359-1365. PubMed ID: 34162655
[TBL] [Abstract][Full Text] [Related]
4. Survival among patients with glioma in the US Military Health System: A comparison with patients in the Surveillance, Epidemiology, and End Results program.
Lin J; Bytnar JA; Theeler BJ; McGlynn KA; Shriver CD; Zhu K
Cancer; 2020 Jul; 126(13):3053-3060. PubMed ID: 32286688
[TBL] [Abstract][Full Text] [Related]
5. Survival among Lung Cancer Patients in the U.S. Military Health System: A Comparison with the SEER Population.
Lin J; Kamamia C; Brown D; Shao S; McGlynn KA; Nations JA; Carter CA; Shriver CD; Zhu K
Cancer Epidemiol Biomarkers Prev; 2018 Jun; 27(6):673-679. PubMed ID: 29531129
[No Abstract] [Full Text] [Related]
6. Comparative study of survival among small cell lung cancer patients in the U.S. military health system and those in the surveillance, epidemiology, and end results (SEER) program.
Lin J; Kamamia C; Brown DW; Shao S; McGlynn KA; Nations JA; Carter CA; Shriver CD; Zhu K
Ann Epidemiol; 2021 Dec; 64():132-139. PubMed ID: 34547444
[TBL] [Abstract][Full Text] [Related]
7. Survival among lung cancer patients: comparison of the U.S. military health system and the surveillance, epidemiology, and end results (SEER) program by health insurance status.
Lin J; Shriver CD; Zhu K
Cancer Causes Control; 2024 Jan; 35(1):21-31. PubMed ID: 37532916
[TBL] [Abstract][Full Text] [Related]
8. Cancer stage at diagnosis: Comparison of insurance status in SEER to the Department of Defense Cancer Registry.
Flanary JT; Lin J; Shriver CD; Zhu K
Cancer Med; 2023 Nov; 12(22):20989-21000. PubMed ID: 37902129
[TBL] [Abstract][Full Text] [Related]
9. Bone Sarcoma Survival in the US Military Health System: Comparison With the SEER Program.
Anderson AB; Kim E; Park AB; Zhu K; Lin J; Shriver CD; Potter BK
J Am Acad Orthop Surg; 2024 Jul; 32(13):e651-e660. PubMed ID: 38684126
[TBL] [Abstract][Full Text] [Related]
10. Differences in Survival between Black and White Patients with Head and Neck Squamous Cell Carcinoma: Comparison of Data from the DOD Central Cancer Registry and SEER.
Lin J; Orestes MI; Shriver CD; Zhu K
Cancer Epidemiol Biomarkers Prev; 2024 Mar; 33(3):426-434. PubMed ID: 38099827
[TBL] [Abstract][Full Text] [Related]
11. Comparative Trends in the Distribution of Lung Cancer Stage at Diagnosis in the Department of Defense Cancer Registry and the Surveillance, Epidemiology, and End Results data, 1989-2012.
Nations JA; Brown DW; Shao S; Shriver CD; Zhu K
Mil Med; 2020 Dec; 185(11-12):e2044-e2048. PubMed ID: 32857164
[TBL] [Abstract][Full Text] [Related]
12. Survival in Pediatric, Adolescent, and Young Adult Patients With Sarcoma in the Military Health System: Comparison With the SEER Population.
Vasta LM; Zanetti RC; Anderson AB; Zhu K; Potter BK; Park AB; Lin J; Shriver CD; Warwick AB
J Pediatr Hematol Oncol; 2021 Aug; 43(6):e832-e840. PubMed ID: 34397617
[TBL] [Abstract][Full Text] [Related]
13. Comparative Trends in the Distribution of Prostate Cancer Stage at Diagnosis in the Department of Defense Cancer Registry and the Surveillance, Epidemiology, and End Results Data, 2004-2014.
Bandi LL; Lin J; Shriver CD; Chesnut GT; Zhu K
Mil Med; 2024 Jun; ():. PubMed ID: 38836854
[TBL] [Abstract][Full Text] [Related]
14. Soft-tissue Sarcoma Survival in the US Military Health System: Comparison With the SEER Program.
Anderson AB; Park AB; Zhu K; Lin J; Shriver CD; Potter BK
J Am Acad Orthop Surg Glob Res Rev; 2022 Jun; 6(6):. PubMed ID: 35727910
[TBL] [Abstract][Full Text] [Related]
15. Incidence of papillary thyroid cancer: Comparison of the military and the general population by race and tumor stage/size.
Bytnar JA; Enewold L; Shriver CD; Zhu K
Cancer Epidemiol; 2024 Apr; 89():102539. PubMed ID: 38340498
[TBL] [Abstract][Full Text] [Related]
16. Cancer incidence in the U.S. military population: comparison with rates from the SEER program.
Zhu K; Devesa SS; Wu H; Zahm SH; Jatoi I; Anderson WF; Peoples GE; Maxwell LG; Granger E; Potter JF; McGlynn KA
Cancer Epidemiol Biomarkers Prev; 2009 Jun; 18(6):1740-5. PubMed ID: 19505907
[TBL] [Abstract][Full Text] [Related]
17. Cancers of Unknown Primary: A Descriptive Study in the U.S. Military Health System.
Bytnar JA; Lin J; Moncur JT; Shriver CD; Zhu K
Mil Med; 2023 Mar; 188(3-4):e516-e523. PubMed ID: 34296267
[TBL] [Abstract][Full Text] [Related]
18. Cancer incidence in the US military: An updated analysis.
Bytnar JA; McGlynn KA; Nealeigh MD; Shriver CD; Zhu K
Cancer; 2024 Jan; 130(1):96-106. PubMed ID: 37725334
[TBL] [Abstract][Full Text] [Related]
19. Widening disparity in survival between white and African-American patients with breast carcinoma treated in the U. S. Department of Defense Healthcare system.
Jatoi I; Becher H; Leake CR
Cancer; 2003 Sep; 98(5):894-9. PubMed ID: 12942554
[TBL] [Abstract][Full Text] [Related]
20. Tumour size and overall survival among surgically treated patients with non-metastatic colon cancer in the U.S. Military Health System.
Alexander M; Lin J; Shriver CD; McGlynn KA; Zhu K
Colorectal Dis; 2021 Jan; 23(1):192-199. PubMed ID: 32976668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
